By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Phillips and F.P. Journe to Sell Unique Piece to Benefit Breast Cancer Research
Investing

Phillips and F.P. Journe to Sell Unique Piece to Benefit Breast Cancer Research

News Room
Last updated: 2024/02/22 at 3:27 AM
By News Room
Share
4 Min Read
SHARE

Phillips and the independent Swiss watch brand F.P. Journe have teamed up to raise funds for breast cancer research by auctioning a one-of-a-kind Élégante timepiece at a private event in Miami on March 2. The watch has no price estimate at this time.

François-Paul Journe took the watch world by surprise a decade ago when he unveiled Élégante, his first watch specifically designed for women. No one could ever have expected a master of mechanical complications to present a quartz watch. But given that women overwhelmingly prefer low-maintenance quartz watches, Journe felt he had to reinvent and upgrade the notion of a battery-powered movement.   

Journe spent eight years in research and development to come up with the slim, tonneau-shaped Élégante, which broke new technical ground with its ingenious electromechanical movement.  

The caliber 1210 is equipped with a motion detection sensor, visible through an aperture in the dial at 4:30. This allows the watch to go to sleep in order to preserve energy after 35 minutes of inactivity. When the watch is asleep, the microprocessor continues to keep time, though the mechanical gears, rotors, and hands come to a standstill and stop consuming energy. The watch wakes up when the sensor detects movement, and the hands automatically adjust to the correct time, following the shortest possible path, either clockwise or counterclockwise. 

MORE: Raquel Welch’s Fur Bikini Heads to Auction in Los Angeles

This advancement on the quartz movement endows Élégante with an impressive eight to 10 years of autonomy when the watch is worn and up to 18 years in standby mode.

In typical Journe fashion, he took the concept to extremes by adding a second movement to separate the seconds hand from the hours and minutes hands. Typically, a quartz watch has a single movement that drives all three hands through a gear train. This configuration causes friction, which results in power loss. So, Journe dispensed with the gear train altogether with a dedicated seconds movement. 

F.P. Journe produces Élégante’s mechanical elements, while the electronic components are produced in Switzerland to meet the brand’s uncompromising quality standards. Unlike typical quartz watches, Élégante shows off its pink-gold-plated movement through a sapphire crystal case back. And it’s even treated to high-horology finishing touches, such as an engraved battery bridge decorated with Cotes de Genève (Geneva stripes) and screw heads that are beveled and polished. 

MORE: Jason Momoa’s Ultra-Quiet Rolls-Royce Phantom has Battery Power

The unique piece that is going on the block in Miami features a 48mm case made of dark gray Titalyt, which is grade five titanium subjected to electro-plasma oxidation to increase hardness and corrosion resistance. The white luminescent dial features bold, black Arabic numerals, and an outer dial with screwed steel elements. And since pink is the color for breast cancer awareness, the number 1 stands out in pink and the watch is fitted with a matching pink strap.  

All proceeds from the Miami sale will benefit the Breast Cancer Research Foundation, the world’s largest private funder of breast cancer research. The event is by invitation only, but those who cannot attend can bid by phone or online by contacting [email protected].

Read the full article here

News Room February 22, 2024 February 22, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Tesla bull Dan Ives talks why he’s still bullish, AT&T COO talks wireless competition

Watch full video on YouTube

Why The U.S. Is Running Out Of Explosives

Watch full video on YouTube

REX American Resources Corporation 2026 Q3 – Results – Earnings Call Presentation (NYSE:REX) 2025-12-05

This article was written byFollowSeeking Alpha's transcripts team is responsible for the…

AI won’t take your job – but someone using it will

Watch full video on YouTube

Could Crypto-Backed Mortgages Put The U.S. Housing Market At Risk?

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?